DeMarc A Hickson1, Jiankang Liu2, Aurelian Bidulescu3, Cecil M Burchfiel4, Herman A Taylor5, Marcy F Petrini2. 1. Jackson Heart Study, Jackson State University, Jackson, MS; School of Medicine, University of Mississippi Medical Center, Jackson, MS. Electronic address: demarc.a.hickson@jsums.edu. 2. School of Medicine, University of Mississippi Medical Center, Jackson, MS. 3. Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, GA. 4. Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Cincinnati, OH. 5. Jackson Heart Study, Jackson State University, Jackson, MS; School of Medicine, University of Mississippi Medical Center, Jackson, MS.
Abstract
BACKGROUND: Impaired lung function has been linked to obesity and systemic inflammation. Pericardial fat has been shown to be associated with anomalies in cardiac structure, function, and atherosclerosis. We hypothesized that pericardial fat may have a similar role in the impairment of lung function. METHODS: Cross-sectional associations of pericardial fat volumes, quantified by multidetector CT scan, with FEV(1) and FVC assessed by spirometry, were investigated in 1,293 participants (54.5 ± 10.8 years; 66.4% women) in the Jackson Heart Study. We also examined whether these associations were independent of visceral adipose tissue (VAT). RESULTS: Pericardial fat was associated with impaired lung function after multivariable adjustment, but these associations generally did not remain after adjustment for VAT. An exception was the FEV(1)/FVC ratio. Higher pericardial fat volumes were associated with higher odds of a restrictive lung pattern and lower odds of airway obstruction. Participants in the highest quartile had the highest odds of a restrictive lung pattern (OR, 1.85; 95% CI, 1.22-2.79, compared with quartile 1), even after adjustment for VAT. The odds of obstruction decreased across increasing quartiles of pericardial fat. These relationships were generally graded, suggesting dose-response trends. CONCLUSIONS: Pericardial fat is generally associated with lower lung function and independently associated with a restrictive lung pattern in middle-aged and elderly adults. Further research is needed to fully understand the mechanisms through which pericardial fat contributes to pulmonary anomalies.
BACKGROUND:Impaired lung function has been linked to obesity and systemic inflammation. Pericardial fat has been shown to be associated with anomalies in cardiac structure, function, and atherosclerosis. We hypothesized that pericardial fat may have a similar role in the impairment of lung function. METHODS: Cross-sectional associations of pericardial fat volumes, quantified by multidetector CT scan, with FEV(1) and FVC assessed by spirometry, were investigated in 1,293 participants (54.5 ± 10.8 years; 66.4% women) in the Jackson Heart Study. We also examined whether these associations were independent of visceral adipose tissue (VAT). RESULTS: Pericardial fat was associated with impaired lung function after multivariable adjustment, but these associations generally did not remain after adjustment for VAT. An exception was the FEV(1)/FVC ratio. Higher pericardial fat volumes were associated with higher odds of a restrictive lung pattern and lower odds of airway obstruction. Participants in the highest quartile had the highest odds of a restrictive lung pattern (OR, 1.85; 95% CI, 1.22-2.79, compared with quartile 1), even after adjustment for VAT. The odds of obstruction decreased across increasing quartiles of pericardial fat. These relationships were generally graded, suggesting dose-response trends. CONCLUSIONS: Pericardial fat is generally associated with lower lung function and independently associated with a restrictive lung pattern in middle-aged and elderly adults. Further research is needed to fully understand the mechanisms through which pericardial fat contributes to pulmonary anomalies.
Authors: G S Nelson; E Y Sayed-Ahmed; C A Kroeker; Y H Sun; H E Keurs; N G Shrive; J V Tyberg Journal: Am J Physiol Heart Circ Physiol Date: 2001-06 Impact factor: 4.733
Authors: Jiankang Liu; Caroline S Fox; Demarc Hickson; Daniel Sarpong; Lynette Ekunwe; Warren D May; Gregory W Hundley; J Jeffery Carr; Herman A Taylor Journal: Diabetes Care Date: 2010-04-22 Impact factor: 17.152
Authors: Thomas M Tadros; Joseph M Massaro; Guido A Rosito; Udo Hoffmann; Ramachandran S Vasan; Martin G Larson; John F Keaney; Izabella Lipinska; James B Meigs; Sekar Kathiresan; Christopher J O'Donnell; Caroline S Fox; Emelia J Benjamin Journal: Obesity (Silver Spring) Date: 2009-10-29 Impact factor: 5.002
Authors: Jiankang Liu; Caroline S Fox; Demarc A Hickson; Warren L May; Jingzhong Ding; J Jeffery Carr; Herman A Taylor Journal: Diabetes Care Date: 2011-01-12 Impact factor: 19.112
Authors: Tong Wu; Marc R Jahangir; Sara M Mensink-Bout; Stefan Klein; Liesbeth Duijts; Edwin H G Oei Journal: Int J Obes (Lond) Date: 2022-02-21 Impact factor: 5.551
Authors: Won Gun Kwack; Yun-Seong Kang; Yun Jeong Jeong; Jin Young Oh; Yoon Ki Cha; Jeung Sook Kim; Young Soon Yoon Journal: J Thorac Dis Date: 2019-12 Impact factor: 2.895
Authors: Michaela R Anderson; John S Kim; Matthew Allison; Jon T Giles; Eric A Hoffman; Jingzhong Ding; R Graham Barr; Anna Podolanczuk Journal: Chest Date: 2021-04-15 Impact factor: 10.262
Authors: Emily S Wan; Peter J Castaldi; Michael H Cho; John E Hokanson; Elizabeth A Regan; Barry J Make; Terri H Beaty; MeiLan K Han; Jeffrey L Curtis; Douglas Curran-Everett; David A Lynch; Dawn L DeMeo; James D Crapo; Edwin K Silverman Journal: Respir Res Date: 2014-08-06
Authors: Paulo de Tarso Müller; Hamilton Domingos; Luiz Armando Pereira Patusco; Gabriel Victor Guimarães Rapello Journal: J Bras Pneumol Date: 2015 Sep-Oct Impact factor: 2.624